FI964284L - Apolipoproteiini E:n polymorfismi ja Alzheimerin taudin hoito - Google Patents
Apolipoproteiini E:n polymorfismi ja Alzheimerin taudin hoito Download PDFInfo
- Publication number
- FI964284L FI964284L FI964284A FI964284A FI964284L FI 964284 L FI964284 L FI 964284L FI 964284 A FI964284 A FI 964284A FI 964284 A FI964284 A FI 964284A FI 964284 L FI964284 L FI 964284L
- Authority
- FI
- Finland
- Prior art keywords
- apolipoprotein
- polymorphism
- alzheimer
- disease treatment
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9408465A GB9408465D0 (en) | 1994-04-27 | 1994-04-27 | Apolipoprotein e polymorphism & treatment of alzheimer's disease |
| PCT/CA1995/000240 WO1995029257A2 (en) | 1994-04-27 | 1995-04-26 | Apolipoprotein e polymorphism and treatment of alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI964284A0 FI964284A0 (fi) | 1996-10-24 |
| FI964284L true FI964284L (fi) | 1996-12-23 |
| FI964284A7 FI964284A7 (fi) | 1996-12-23 |
Family
ID=10754293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI964284A FI964284A7 (fi) | 1994-04-27 | 1995-04-26 | Apolipoproteiini E:n polymorfismi ja Alzheimerin taudin hoito |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5935781A (fi) |
| EP (1) | EP0804615B1 (fi) |
| JP (1) | JP3285585B2 (fi) |
| AT (1) | ATE247717T1 (fi) |
| AU (1) | AU693193B2 (fi) |
| CA (1) | CA2188933C (fi) |
| DE (1) | DE69531557T2 (fi) |
| FI (1) | FI964284A7 (fi) |
| GB (1) | GB9408465D0 (fi) |
| MX (1) | MX9605176A (fi) |
| NO (1) | NO964543L (fi) |
| NZ (1) | NZ284412A (fi) |
| WO (1) | WO1995029257A2 (fi) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7049078B2 (en) * | 1994-04-27 | 2006-05-23 | Judés Poirier | Apolipoprotein E polymorphism and treatment of alzheimer's disease |
| GB9408465D0 (en) * | 1994-04-27 | 1994-06-22 | Univ Mcgill | Apolipoprotein e polymorphism & treatment of alzheimer's disease |
| US6022683A (en) * | 1996-12-16 | 2000-02-08 | Nova Molecular Inc. | Methods for assessing the prognosis of a patient with a neurodegenerative disease |
| US5767337A (en) * | 1995-07-31 | 1998-06-16 | Duke University | Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice |
| GB9525481D0 (en) * | 1995-12-13 | 1996-02-14 | Royston M C | Novel method |
| ES2115553B1 (es) * | 1996-10-23 | 1999-02-16 | Boehringer Ingelheim Espana | Metodo para detectar la presencia de polimorfismos de dna, estuche de ensayo y acidos nucleicos recombinantes correspondientes. |
| FR2765591B1 (fr) * | 1997-07-01 | 2002-08-09 | Pasteur Institut | Procede de diagnostic de la maladie d'alzheimer |
| WO1999015159A2 (en) * | 1997-09-24 | 1999-04-01 | Nova Molecular, Inc. | Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| ES2142248B1 (es) * | 1997-11-20 | 2000-11-16 | Univ Madrid Autonoma | Polimorfismos en el promotor del gen humano de la apolipoproteina e, y sus usos para aplicaciones diagnosticas y terapeuticas. |
| US6251587B1 (en) | 1997-12-16 | 2001-06-26 | Nova Molecular, Inc. | Method for determining the prognosis of a patient with a neurological disease |
| WO1999058640A2 (en) | 1998-05-11 | 1999-11-18 | Philadelphia Health And Education Corporation | Mct-1, a human oncogene |
| AU773765B2 (en) * | 1998-10-01 | 2004-06-03 | Variagenics, Inc. | Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of variant GPIIIA and/or variant GPIIB allele |
| US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
| US6573049B1 (en) | 1999-07-26 | 2003-06-03 | Nuvelo, Inc. | Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease |
| US6432643B1 (en) * | 1999-10-22 | 2002-08-13 | Duke University | Method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels |
| EP1113081A1 (en) * | 1999-12-28 | 2001-07-04 | Institut Pasteur De Lille | Implication of a known gene named CP2/LSF/LBP-1 in Alzheimer's disease |
| US6453244B1 (en) * | 2000-02-10 | 2002-09-17 | Stanford University | Detection of polymorphisms by denaturing high-performance liquid chromatography |
| US20020019746A1 (en) * | 2000-03-16 | 2002-02-14 | Rienhoff Hugh Y. | Aggregating persons with a select profile for further medical characterization |
| DE60138019D1 (de) * | 2000-05-01 | 2009-04-30 | Accera Inc | Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung |
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US20020010552A1 (en) * | 2000-05-26 | 2002-01-24 | Hugh Rienhoff | System for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area network |
| US20030105082A1 (en) * | 2001-12-03 | 2003-06-05 | Murphy Greer Marechal | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
| US20040106124A1 (en) * | 2001-02-12 | 2004-06-03 | Murphy Greer M. | Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 and for improving the terapeutic response of humans having major depression and carrying the gene for apolipoprotein e4 |
| US6399310B1 (en) | 2001-02-12 | 2002-06-04 | Akzo Nobel N.V. | Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 |
| US20040005566A1 (en) * | 2002-07-02 | 2004-01-08 | Genelink, Inc. | Kits and methods for assessing cardiovascular health |
| CA2573673A1 (en) | 2004-07-16 | 2006-01-26 | Proteosys Ag | Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| DK2500017T3 (da) * | 2006-04-03 | 2017-11-06 | Accera Inc | Anvendelse af ketogene forbindelser til behandling af aldersrelateret hukommelsessvækkelse |
| US20080249103A1 (en) * | 2006-11-15 | 2008-10-09 | Sirtris Pharmaceuticals, Inc. | Sirtuin polymorphisms and methods of use thereof |
| EP2650379B1 (en) | 2007-07-31 | 2015-09-16 | Accera, Inc. | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| CA2729622C (en) * | 2008-07-03 | 2017-07-25 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| US8105809B2 (en) * | 2008-07-03 | 2012-01-31 | Accera, Inc. | Enzymatic synthesis of acetoacetate esters and derivatives |
| WO2010081823A1 (en) | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzepine as otoprotective agent |
| US20110177061A1 (en) | 2009-07-10 | 2011-07-21 | Martek Biosciences Corporation | Methods of treating and preventing neurological disorders using docosahexaenoic acid |
| EP3555629A4 (en) | 2016-12-18 | 2020-11-25 | Selonterra, Inc. | USE OF APOE4 PATTERNED MEDIATION GENES FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE |
| EP3628315A1 (en) | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Combination of acetylcholinesterase inhibitor and 5-ht4 receptor agonist as neuroprotective agent in the treatment of neurodegenerative diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994009155A1 (en) * | 1992-10-13 | 1994-04-28 | Duke University | Methods of detecting alzheimer's disease |
| JPH09500645A (ja) * | 1993-07-22 | 1997-01-21 | ワーナー−ランバート・コンパニー | 制御放出タクリン薬物送達システムおよびその製造方法 |
| US5643960A (en) * | 1994-04-15 | 1997-07-01 | Duke University | Method of delaying onset of alzheimer's disease symptoms |
| GB9408465D0 (en) * | 1994-04-27 | 1994-06-22 | Univ Mcgill | Apolipoprotein e polymorphism & treatment of alzheimer's disease |
| GB9415073D0 (en) * | 1994-06-27 | 1994-09-14 | Smithkline Beecham Plc | Novel method |
| US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| GB9414624D0 (en) * | 1994-07-20 | 1994-09-07 | Smithkline Beecham Plc | Novel method |
-
1994
- 1994-04-27 GB GB9408465A patent/GB9408465D0/en active Pending
-
1995
- 1995-04-26 WO PCT/CA1995/000240 patent/WO1995029257A2/en not_active Ceased
- 1995-04-26 EP EP95916530A patent/EP0804615B1/en not_active Expired - Lifetime
- 1995-04-26 AT AT95916530T patent/ATE247717T1/de not_active IP Right Cessation
- 1995-04-26 CA CA002188933A patent/CA2188933C/en not_active Expired - Fee Related
- 1995-04-26 DE DE69531557T patent/DE69531557T2/de not_active Expired - Lifetime
- 1995-04-26 NZ NZ284412A patent/NZ284412A/xx not_active IP Right Cessation
- 1995-04-26 US US08/727,637 patent/US5935781A/en not_active Expired - Lifetime
- 1995-04-26 JP JP52724895A patent/JP3285585B2/ja not_active Expired - Fee Related
- 1995-04-26 AU AU23006/95A patent/AU693193B2/en not_active Ceased
- 1995-04-26 FI FI964284A patent/FI964284A7/fi not_active IP Right Cessation
-
1996
- 1996-10-25 NO NO964543A patent/NO964543L/no not_active Application Discontinuation
- 1996-10-28 MX MX9605176A patent/MX9605176A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69531557T2 (de) | 2004-06-17 |
| MX9605176A (es) | 1998-06-30 |
| EP0804615B1 (en) | 2003-08-20 |
| WO1995029257A3 (en) | 1995-11-23 |
| CA2188933A1 (en) | 1995-11-02 |
| CA2188933C (en) | 2000-11-14 |
| WO1995029257A2 (en) | 1995-11-02 |
| JPH10500288A (ja) | 1998-01-13 |
| NO964543L (no) | 1996-12-20 |
| JP3285585B2 (ja) | 2002-05-27 |
| FI964284A0 (fi) | 1996-10-24 |
| NO964543D0 (no) | 1996-10-25 |
| NZ284412A (en) | 2000-01-28 |
| GB9408465D0 (en) | 1994-06-22 |
| EP0804615A1 (en) | 1997-11-05 |
| AU693193B2 (en) | 1998-06-25 |
| AU2300695A (en) | 1995-11-16 |
| ATE247717T1 (de) | 2003-09-15 |
| US5935781A (en) | 1999-08-10 |
| DE69531557D1 (de) | 2003-09-25 |
| FI964284A7 (fi) | 1996-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI964284L (fi) | Apolipoproteiini E:n polymorfismi ja Alzheimerin taudin hoito | |
| CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
| FI962557L (fi) | PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa | |
| FI933946A7 (fi) | Hypoglykeemisinä aineina ja Alzheimerin taudin hoidossa käyttökelpoisia yhdisteitä | |
| FI964060A0 (fi) | Kosketusjousi | |
| FI951701A7 (fi) | Menetelmät Alzheimerin taudin tunnistamiseksi | |
| EP1007048A4 (en) | IDENTIFICATION OF MEANS FOR TREATING ALZHEIMERISCHEN DISEASE | |
| KR970704445A (ko) | 페노티아진 및/또는 티옥산틴을 사용한 알츠하이머 병의 치료 및/또는 예방 방법(methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes | |
| FI953915A0 (fi) | Dupuytrenin taudin lievittämiseen | |
| NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
| BR9506419A (pt) | Composiçao microbicida e processo de esterilizaçao | |
| AU1189395A (en) | Apolipoprotein e polymorphism and alzheimer's disease | |
| BR9500163A (pt) | Composição fungicida e processo de tratamento de culturas | |
| ITRM940124V0 (it) | "brandina o cuccia pieghegole e/o smontabile" | |
| AU8700998A (en) | Use of Apolipoprotein polymorphism E in the treatment of Alzheimer's disease | |
| KR940022019U (ko) | 남성물리치료기 | |
| KR960016090U (ko) | 환자복 | |
| KR950031762U (ko) | 브라케트의 효율적인 구조 | |
| ITTO940810A0 (it) | "sedia" | |
| KR950024858U (ko) | 카리프트의 풋보드 확장장치 | |
| KR950024510U (ko) | 운전자용 졸음 방지구 | |
| KR960001317U (ko) | 카스테레오의 고정구조 | |
| KR960006682U (ko) | 튜너의 폰잭핀 | |
| UA25492A (uk) | Спосіб лікуваhhя хвороби гіршпруhга | |
| KR960021496U (ko) | 운전자의 발 지지대 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |